ZJYL — Jin Medical International Cashflow Statement
0.000.00%
- $407.02m
- $394.44m
- $19.82m
Annual cashflow statement for Jin Medical International, fiscal year end - September 30th, USD millions except per share, conversion factor applied.
2019 September 30th | 2020 September 30th | 2021 September 30th | 2022 September 30th | 2023 September 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | PROSPECTUS | 20-F |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 3.65 | 2.21 | 2.63 | 2.71 | 2.88 |
Depreciation | |||||
Deferred Taxes | |||||
Non-Cash Items | 0.027 | 0.08 | -0.095 | 0.029 | 0.113 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -5.32 | -0.035 | 2.96 | -1.43 | -0.201 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Prepaid Expenses | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Payable / Accrued Expenses | |||||
Change in Taxes Payable | |||||
Change in Other Liabilities | |||||
Cash from Operating Activities | -1.33 | 2.5 | 5.84 | 1.58 | 3.11 |
Capital Expenditures | -0.039 | -0.142 | -0.043 | -0.04 | -0.114 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | 0.166 | -1.82 | -1.02 | -0.081 | -7.62 |
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | 0.127 | -1.96 | -1.07 | -0.121 | -7.73 |
Financing Cash Flow Items | 0.093 | 0.011 | -0.104 | 0.122 | -4.47 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 2.36 | -0.344 | -2.87 | 0.122 | 6.91 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 1.09 | -0.278 | 2.01 | 1.12 | 2.14 |